Absci (ABSI) Shares Outstanding (2020 - 2026)

Absci (ABSI) posted Shares Outstanding (Entity) of $155.9 million for Q1 2026, up 2.9% sequentially from $151.5 million in Q4 2025, and up 22.22% YoY from $127.6 million in Q1 2025.

Absci (ABSI) Shares Outstanding (2020 - 2026) Analysis & Trends

Absci has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $155.9 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 22.22% year-over-year to $155.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $155.9 million (up 22.22% YoY) and the FY2025 annual result came in at $151.5 million, up 31.34% from the prior year.
  • Shares Outstanding (Entity) climbed to $155.9 million in Q1 2026 per ABSI's latest filing, from $151.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $155.9 million in Q1 2026 and troughed at $92.4 million in Q4 2022.
  • A 5-year average of $113.7 million and a median of $113.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) surged 425.94% in 2022, then retreated 0.38% in 2023.
  • Over 5 years, Shares Outstanding (Entity) stood at $92.4 million in 2022, then rose by 0.73% to $93.1 million in 2023, then gained by 23.93% to $115.4 million in 2024, then surged by 31.34% to $151.5 million in 2025, then advanced by 2.9% to $155.9 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $155.9 million, $151.5 million, and $150.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Absci 1.58 Bn 1.37 Bn - 157.47 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 157.47 Mn
Mar 31, 2026 152.96 Mn
Dec 31, 2025 136.78 Mn
Sep 30, 2025 143.77 Mn
Jun 30, 2025 127.59 Mn
Mar 31, 2025 124.46 Mn
Dec 31, 2024 110.24 Mn
Sep 30, 2024 113.61 Mn
Jun 30, 2024 112.93 Mn
Mar 31, 2024 99.39 Mn
Dec 31, 2023 92.03 Mn
Sep 30, 2023 92.22 Mn
Jun 30, 2023 91.83 Mn
Mar 31, 2023 91.48 Mn
Dec 31, 2022 90.85 Mn
Sep 30, 2022 91.11 Mn
Jun 30, 2022 90.67 Mn
Mar 31, 2022 90.27 Mn
Dec 31, 2021 49.69 Mn
Sep 30, 2021 73.29 Mn